Brief: Synact Pharma Proposes EGM For Share Acquisition Authorization
29/09/2025 06:55
Sept 29 (Reuters) - SynAct Pharma AB SYNACT.ST: PROPOSES EGM FOR SHARE ACQUISITION AUTHORIZATION BOARD PROPOSES ACQUISITION OF OWN SHARES UP TO SEK 10 MILLION ACQUISITION LIMITED TO 10% OF TOTAL SHARES Source text: ID:nMFN25LfG8 Further company coverage: SYNACT.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on SynAct Pharma AB
See all newsBrief: SynAct: Shareholding Board, Management Sign Lock-Up Agreements
Sweden's SynAct Pharma posts wider Q1 net loss as expenses rise
Brief: SynAct Pharma Q1 Sales SEK 0
Brief: SynAct Pharma Carries Out Directed Issue Of New Shares
Brief: Synact Pharma Appoints Ann Kristin Led As CFO Effective March 2026